PPL Corp., based in Allentown, Pennsylvania, has generation, transmission, distribution, and wholesale operations. Its utilities deliver electricity and natural gas on a regulated basis to customers in Pennsylvania, Kentucky, Rhode Island, and Virginia. The company also serves natural gas customers in Kentucky. The company has 3.5 million customers. In 2023, Kentucky regulated utilities accounted for 42% of total revenue while Pennsylvania regulated utilities accounted for 36%. PPL has regulated utility operations in Pennsylvania (PPL Electric, 1.4 million customers), Kentucky (KU and Louisville Gas and Electric, 1.3 million), Virginia (less than 0.1 million) and Rhode Island (Rhode Island Energy, previously called Narragansett Electric, 0.8 million). PPL has significant coal usage as a generating fuel. Management is targeting net-zero emissions by 2050, which is in line with utilities with coal plants. The company's market cap is $24 billion.

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Scor is the world’s fourth-largest reinsurer selling both nonlife and life reinsurance. Scor global life sells reinsurance on life protection and longevity reinsurance and offers financial solutions. Financial solutions provide liquidity, balance sheet, and solvency solutions to Scor’s clients and are typically used by insurers to stabilize earnings, optimise solvency, or fund growth. Scor global nonlife reinsures property that includes damage to assets and business interruption losses caused by fire or other perils, including natural catastrophes. Within motor reinsurance, Scor reinsures both property and damage and bodily injury. Casualty treaties are written to cover general liability, product liability, and personal indemnity. Scor global nonlife also sells specialty insurance.

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.